Page 488 - Basic _ Clinical Pharmacology ( PDFDrive )
P. 488

27                          Skeletal Muscle Relaxants
                         C  H   A  P   T  E  R










                                                     Marieke Kruidering-Hall, PhD, &
                                                     Lundy Campbell, MD











                   C ASE  STUD Y

                   A 70-kg, 45-year-old single, unrestrained male driver, is     to facilitate tracheal intubation? What is the proper dose for
                   involved in a motor vehicle crash. He is rushed to a nearby   your chosen muscle relaxant? After intravenous infusion of
                   level 1 trauma center where he is found to have multiple   your chosen muscle relaxant, you are unable to adequately
                   facial fractures, a severe, unstable cervical spine injury,   visualize the patient’s larynx and vocal cords and cannot
                   and significant left eye trauma. Further examination of   successfully pass an endotracheal tube. You switch to mask
                   his left eye reveals rupture of his globe. The ophthalmolo-  ventilation but are barely able to mask ventilate the patient,
                   gist requests emergency surgery to repair and save his eye.   and you become worried that you will soon lose the ability
                   Because the patient has suffered a recent trauma, you decide   to ventilate at all. Is there a medication that you can give
                   to perform a rapid sequence intubation in preparation for   to facilitate rapid return of spontaneous ventilation in this
                   the surgical procedure. What muscle relaxant would you use   situation?




                 Drugs that affect skeletal muscle function include two different   NEUROMUSCULAR BLOCKING DRUGS
                 therapeutic groups: those used during surgical procedures and
                 in the intensive care unit (ICU) to produce muscle paralysis   History
                 (ie, neuromuscular blockers), and those used to reduce spas-
                 ticity in a variety of painful conditions (ie, spasmolytics and   During the 16th century, European explorers found that
                 antispasmodics). Neuromuscular blocking drugs interfere with   natives in the Amazon Basin of South America were using
                 transmission at the neuromuscular end plate and lack central   curare, an arrow poison that produced skeletal muscle paraly-
                 nervous system (CNS)  activity.  These  compounds are used   sis, to kill animals. The active compound, d-tubocurarine, and
                 primarily as adjuncts during general anesthesia to optimize   its modern synthetic analogs have had a major influence on
                 surgical conditions and to facilitate endotracheal intubation in   the practice of anesthesia and surgery and have proved useful
                 order to ensure adequate ventilation. Drugs in the spasmolytic   in understanding the basic mechanisms involved in neuromus-
                 group have traditionally been called “centrally acting” muscle   cular transmission.
                 relaxants and are used primarily to treat chronic back pain and   Normal Neuromuscular Function
                 painful fibromyalgic conditions. Dantrolene, an agent that has
                 no significant central effects and is used primarily to treat a rare   The mechanism of neuromuscular transmission at the motor end
                 anesthetic-related complication, malignant hyperthermia, is   plate is similar to that described for preganglionic cholinergic
                 also discussed in this chapter.                     nerves  in Chapter 6. The arrival of  an action potential at the







                 474
   483   484   485   486   487   488   489   490   491   492   493